imidazolecarboxamide has been researched along with Multiple Myeloma in 1 studies
*Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gui, Y; Hu, Z; Huang, C; Li, R; Ling, Z; Wang, Y; Yao, Y | 1 |
1 other study(ies) available for imidazolecarboxamide and Multiple Myeloma
| Article | Year |
|---|---|
5-Amino-4-Imidazolecarboxamide Ribonucleotide Transformylase/IMP Cyclohydrolase Polymorphisms Affect the Susceptibility to Multiple Myeloma.
Topics: Aminoimidazole Carboxamide; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Hydroxymethyl and Formyl Transferases; Multienzyme Complexes; Multiple Myeloma; Nucleotide Deaminases; Polymorphism, Single Nucleotide; Ribonucleotides | 2022 |